HTG Molecular Diagnostics, Inc.
HTGM · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $354,824 | $3,759,384 | $3,746,203 | $4,848,270 |
| - Cash | $12,211 | $9,600 | $22,398 | $7,620 |
| + Debt | $4,834 | $11,710 | $12,644 | $11,254 |
| Enterprise Value | $347,447 | $3,761,493 | $3,736,450 | $4,851,905 |
| Revenue | $6,366 | $8,907 | $8,549 | $19,204 |
| % Growth | -28.5% | 4.2% | -55.5% | – |
| Gross Profit | $1,794 | $4,812 | $4,557 | $10,293 |
| % Margin | 28.2% | 54% | 53.3% | 53.6% |
| EBITDA | -$20,140 | -$19,560 | -$17,962 | -$16,601 |
| % Margin | -316.4% | -219.6% | -210.1% | -86.4% |
| Net Income | -$21,594 | -$17,145 | -$20,870 | -$19,298 |
| % Margin | -339.2% | -192.5% | -244.1% | -100.5% |
| EPS Diluted | -0.24 | -0.3 | -0.32 | -0.5 |
| % Growth | 20% | 6.3% | 36% | – |
| Operating Cash Flow | -$18,408 | -$16,509 | -$16,292 | -$16,696 |
| Capital Expenditures | -$23 | -$644 | -$454 | -$1,103 |
| Free Cash Flow | -$18,431 | -$17,153 | -$16,746 | -$17,799 |